Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
23.47
+0.79 (3.51%)
May 12, 2025, 1:10 PM - Market open
KMTS Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for KMTS stock have an average target of 27, with a low estimate of 23 and a high estimate of 29. The average target predicts an increase of 15.04% from the current stock price of 23.47.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for KMTS stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 |
|---|---|
| Strong Buy | 1 |
| Buy | 3 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $24 → $23 | Hold | Maintains | $24 → $23 | -2.00% | Apr 16, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates $29 | Buy | Initiates | $29 | +23.56% | Mar 31, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $28 | Buy | Initiates | $28 | +19.30% | Mar 31, 2025 |
| Stifel | Stifel | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +19.30% | Mar 31, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $24 | Hold | Initiates | $24 | +2.26% | Mar 31, 2025 |
Financial Forecast
Revenue This Year
n/a
from 27.81M
Revenue Next Year
n/a
EPS This Year
n/a
from -953.06
EPS Next Year
n/a
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.